I’m not sure you understand what proof of concept means. The fact you mentioned phase 3 trials makes me question your understanding of medical devices. Actually I was never questioning it, it’s clear you don’t understand anything to do with this stock, or any in this field.
Ann: BTM delivers positive First in Man results in Cell Therapies, page-78
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.035(2.87%) |
Mkt cap ! $818.6M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.15 | $1.635M | 1.394M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18287 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 42827 | 3 |
View Market Depth
| Last trade - 16.15pm 23/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |